Trial Profile
Pharmacokinetics of Invanz (Ertapenem) in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2015
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- 09 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 May 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 09 Apr 2009 New trial record